Sagent Pharmaceuticals Announces FDA Approval Of Mesna Injection

Links shared publicly online about this topic.

  • 1,224
    total visits

Sagent Pharmaceuticals Announces FDA Approval Of Mesna Injection

medicalnewstoday.com

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mes

View full resource at medicalnewstoday.com

Tags: Cancer, Drug, Pharma, FDA

  • Share

Most Recently Shared on April 22, 2010 at 12:08 am By:

mnt_cancer MNT Cancer News

Sagent Pharmaceuticals Announces FDA Approval Of Mesna Injection http://mnt.to/3Bxt #cancer

2 years ago...

Also Shared By:

MNT Drug Approvals MNT Drug Approvals

MNT Pharma News MNT Pharma News

Sagent Pharmaceuticals Announces FDA Approval Of Midazolam Injection, USP

medicalnewstoday.com — “Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expeView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 5:07 pm By:

medical_tweets medical_tweets Health News

Sagent Pharmaceuticals Announces FDA Approval Of Midazolam Injection, USP Sagent Pharmaceuticals, Inc., a privately-hel.. http://dld.bz/9eTW

1 year ago...

Sagent launches chemotherapy agent topotecan hydrochloride for injection

news-medical.net — “Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 9:10 am By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: Sagent launches chemotherapy agent topotecan hydrochloride for injection: Sagent Pharmaceuticals,... http://bit.ly/hpKyDG

1 year ago...

Sagent Pharmaceuticals Announces FDA Approval Of Bacitracin For Injection, USP

medicalnewstoday.com — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 15, 2010 at 3:56 pm By:

Lung_Breathing Lungs and Breathing OW Health

Sagent Pharmaceuticals Announces FDA Approval Of Bacitracin For Injection, USP: Sagent Pharmaceuticals, Inc., a pr... http://bit.ly/bxy17L

2 years ago...

FDA approves Sagent's bacitracin for pneumonia and empyema

news-medical.net — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free, latex-free, single-dose vial packaged both individually and in packages of ten.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 13, 2010 at 4:46 am By:

NewsMedical News-Medical.Net Health News

FDA approves Sagent's bacitracin for pneumonia and empyema: Sagent Pharmaceuticals, Inc., a privately held special... http://bit.ly/b1TeIw

2 years ago...

FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis

news-medical.net — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 19, 2010 at 1:35 pm By:

NewsMedical News-Medical.Net Health News

FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis: Sagent Pharmaceuticals, Inc., a pri... http://bit.ly/dlkfZu

2 years ago...

Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP

medicalnewstoday.com — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to contrView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 9, 2010 at 6:15 pm By:

mnt_clinical MNT Clinical Trials Health News

Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP http://mnt.to/3xnF #clinicaltrials

2 years ago...

Advertisement